Review of structural design guiding the development of lipid nanoparticles for nucleic acid delivery
The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, the vast design space of LNPs, including tunable lipid compositions, customizable cargo loading, and surface modifications, enables tailored solutions for a range of cell types and delivery goals.37,90,95,96”
From Human T cell engineering via serial delivery of mRNA encapsulated within lipid nanoparticles (2026) · cites this paper as [95]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipid nanoparticles for mRNA delivery
Hou, X., Zaks, T., Langer, R., & Dong, Y. (2021) · Nature Reviews Materials · doi:10.1038/s41578-021-00358-0 · Cited by 4,076
Cheng, Q., Wei, T., Farbiak, L., Johnson, L. T., Dilliard, S. A., & Siegwart, D. J. (2020) · Nature Nanotechnology · doi:10.1038/s41565-020-0669-6 · Cited by 2,383 · cited 2×
“The discovery of selective organ targe-tingLNPs that include an additional lipid with diverse charge has been reported as a way to modulate delivery between the liver, lung and spleen [50].”
BackgroundNonviral vectors for gene delivery
Mintzer, M. A., & Simanek, E. E. (2009) · Chemical Reviews · doi:10.1021/cr800409e · Cited by 2,366
Rational design of cationic lipids for siRNA delivery
Semple, S. C., Akinc, A., Chen, J., Sandhu, A. P., Mui, B. L., Cho, C. K., Sah, D. W. Y., Stebbing, D., Crosley, E. J., Yaworski, E., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1602 · Cited by 1,822 · cited 1×
“A very popular CIL, used to encapsulate short interfering (si)RNA, is hepta-triaconta-6,9,28,31-tetraen-19-y14-(dimethylamino) butanoate[22]alsoknownasDLin-MC3-DMA or simply MC3.”
BackgroundGilleron, J., Querbes, W., Zeigerer, A., Borodovsky, A., Marsico, G., Schubert, U., Manygoats, K., Seifert, S., Andree, C., Stöter, M., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2612 · Cited by 1,681
mRNA-lipid nanoparticle COVID-19 vaccines: structure and stability
Schoenmaker, L., Witzigmann, D., Kulkarni, J. A., Verbeke, R., Kersten, G., Jiskoot, W., & Crommelin, D. J. A. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120586 · Cited by 1,566
Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivo
Jayaraman, M., Ansell, S. M., Mui, B. L., Tam, Y. K., Chen, J., Du, X., Butler, D., Eltepu, L., Matsuda, S., Narayanannair, J. K., et al. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201203263 · Cited by 1,267
Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms
Akinc, A., Querbes, W., De, S., Qin, J., Frank-Kamenetsky, M., Jayaprakash, K. N., Jayaraman, M., Rajeev, K. G., Cantley, W. L., Dorkin, J. R., et al. (2010) · Molecular Therapy · doi:10.1038/mt.2010.85 · Cited by 1,261
Safety and efficacy of RNAi therapy for transthyretin amyloidosis
Coelho, T., Adams, D., Silva, A., Lozeron, P., Hawkins, P. N., Mant, T., Perez, J., Chiesa, J., Warrington, S., Tranter, E., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1208760 · Cited by 971
Visualizing lipid-formulated siRNA release from endosomes and target gene knockdown
Wittrup, A., Ai, A., Liu, X., Hamar, P., Trifonova, R., Charisse, K., Manoharan, M., Kirchhausen, T., & Lieberman, J. (2015) · Nature Biotechnology · doi:10.1038/nbt.3298 · Cited by 693 · cited 2×
“The real bottleneck is the escape of NPs and their intact payload from the endosome into the cytosol [53].”
BackgroundInfluentialKulkarni, J. A., Darjuan, M. M., Mercer, J. E., Chen, S., van der Meel, R., Thewalt, J. L., Tam, Y. Y. C., & Cullis, P. R. (2018) · ACS Nano · doi:10.1021/acsnano.8b01516 · Cited by 663
Liu, S., Cheng, Q., Wei, T., Yu, X., Johnson, L. T., Farbiak, L., & Siegwart, D. J. (2021) · Nature Materials · doi:10.1038/s41563-020-00886-0 · Cited by 653 · cited 1×
“Liu et al. [55] demonstrated that improved mRNA delivery could be obtained by tuning the chemical structure of the ionizable lipid.”
BackgroundPatel, S., Ashwanikumar, N., Robinson, E., Xia, Y., Mihai, C., Griffith, J. P., Hou, S., Esposito, A. A., Ketova, T., Welsher, K., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14527-2 · Cited by 601 · cited 1×
“Another recent study shows that the type of sterol used also influences LNP structure and function [42].”
BackgroundOpportunities and Challenges in the Delivery of mRNA-Based Vaccines
Wadhwa, A., Aljabbari, A., Lokras, A., Foged, C., & Thakur, A. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12020102 · Cited by 584 · cited 1×
“Further, once the cellular delivery of NA is accomplished, the components of the NPs must be able to degrade safely, or if not, there is the risk of safety concerns such as apoptosis or necrosis caused by the biomaterial carrier [9] and mutagenesis caused from NA cargo [10].”
BackgroundYanez Arteta, M., Kjellman, T., Bartesaghi, S., Wallin, S., Wu, X., Kvist, A. J., Dabkowska, A., Székely, N., Radulescu, A., Bergenholtz, J., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1720542115 · Cited by 534
Semple, S. C., Klimuk, S. K., Harasym, T. O., Dos Santos, N., Ansell, S. M., Wong, K. F., Maurer, N., Stark, H., Cullis, P. R., Hope, M. J., et al. (2001) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(00)00343-6 · Cited by 454
Linkage between endosomal escape of LNP-mRNA and loading into EVs for transport to other cells
Maugeri, M., Nawaz, M., Papadimitriou, A., Angerfors, A., Camponeschi, A., Na, M., Hölttä, M., Skantze, P., Johansson, S., Sundqvist, M., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12275-6 · Cited by 428
Sebastiani, F., Yanez Arteta, M., Lerche, M., Porcar, L., Lang, C., Bragg, R. A., Elmore, C. S., Krishnamurthy, V. R., Russell, R. A., Darwish, T., et al. (2021) · ACS Nano · doi:10.1021/acsnano.0c10064 · Cited by 409 · cited 4×
“Data in A and C are replotted from the study by Sebastiani et al. [7]; data in B are reproduced from the study by Kulkarni et al. [11]; panels D –”
MethodInfluentialEvers, M. J. W., Kulkarni, J. A., van der Meel, R., Cullis, P. R., Vader, P., & Schiffelers, R. M. (2018) · Small Methods · doi:10.1002/smtd.201700375 · Cited by 332 · cited 1×
“…simple t-mixers, are used for scaling-up clinical and commercial manufacture of RNA LNP drug products since they are easy and cheap to scale and have the potential to form NPs with similar CQAs based on the organic NP precipitation principle depending on the geometry and the speed of mixing [66].”
MethodA modular platform for targeted RNAi therapeutics
Kedmi, R., Veiga, N., Ramishetti, S., Goldsmith, M., Rosenblum, D., Dammes, N., Hazan-Halevy, I., Nahary, L., Leviatan-Ben-Arye, S., Harlev, M., et al. (2018) · Nature Nanotechnology · doi:10.1038/s41565-017-0043-5 · Cited by 320
Polysarcosine-functionalized lipid nanoparticles for therapeutic mRNA delivery
Nogueira, S. S., Schlegel, A., Maxeiner, K., Weber, B., Barz, M., Schroer, M. A., Blanchet, C. E., Svergun, D. I., Ramishetti, S., Peer, D., et al. (2020) · ACS Applied Nano Materials · doi:10.1021/acsanm.0c01834 · Cited by 252
Progress in the development of lipopolyplexes as efficient non-viral gene delivery systems
Rezaee, M., Oskuee, R. K., Nassirli, H., & Malaekeh-Nikouei, B. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.06.023 · Cited by 200
Research works printed but not linked: 43
- Friedmann, 1992, A brief history of gene therapy, Nat Genet, 2, 93, 10.1038/ng1092-93 · DOI · Paper page
- Davidson, 2011, Current prospects for RNA interference-based therapies, Nat Rev Genet, 12, 329, 10.1038/nrg2968 · DOI · Paper page
- Juliano, 2014, Cellular uptake and intracellular trafficking of oligonucleotides: implications for oligonucleotide pharmacology, Nucleic Acid Therapeut, 24, 101, 10.1089/nat.2013.0463 · DOI · Paper page
- Mohammadinejad, 2019, Necrotic, apoptotic and autophagic cell fates triggered by nanoparticles, Autophagy, 15, 4, 10.1080/15548627.2018.1509171 · DOI · Paper page
- Vaheri, 1965, Infectious poliovirus RNA: a sensitive method of assay, Virology, 27, 434, 10.1016/0042-6822(65)90126-1 · doi:10.1016/0042-6822(65)90126-1
- Rädler, 1997, Structure of DNA-cationic liposome complexes: DNA intercalation in multilamellar membranes in distinct interhelical packing regimes, Science, 275, 810, 10.1126/science.275.5301.810 · DOI · Paper page
- Koltover, 1998, An inverted hexagonal phase of cationic liposome-DNA complexes related to DNA release and delivery, Science, 281, 78, 10.1126/science.281.5373.78 · DOI · Paper page
- Radhakrishnan, 2022, Influence of micellar size on the structure of surfactant-DNA complexes, Phys Rev E, 105, 10.1103/PhysRevE.105.064504 · doi:10.1103/physreve.105.064504
- Kim, 2015, Topologically active siRNA delivery, ACS Nano, 9, 10214, 10.1021/acsnano.5b03902 · DOI
- Tang, 1998, Introduction of a disulfide bond into a cationic lipid enhances transgene expression of plasmid DNA, Biochem Biophys Res Commun, 242, 141, 10.1006/bbrc.1997.7923 · DOI
- Koynova, 2007, Lipoplex formulation of superior efficacy exhibits high surface activity and fusogenicity, and readily releases DNA, Biochim Biophys Acta Biomembr, 1768, 375, 10.1016/j.bbamem.2006.10.016 · DOI
- Urits, 2020, A review of patisiran (ONPATTRO®) for the treatment of polyneuropathy in people with hereditary transthyretin amyloidosis, Neurol. Ther., 9, 301, 10.1007/s40120-020-00208-1 · DOI · Paper page
- Ganesan, 2017, Lipid nanoparticles: different preparation techniques, characterization, hurdles, and strategies for the production of solid lipid nanoparticles and nanostructured lipid carriers for oral drug delivery, Sustain. Chem. Pharm., 6, 37, 10.1016/j.scp.2017.07.002 · DOI · Paper page
- Mourdikoudis, 2018, Characterization techniques for nanoparticles: comparison and complementarity upon studying nanoparticle properties, Nanoscale, 10, 12871, 10.1039/C8NR02278J · DOI · Paper page
- Jia, 2021, Enabling online determination of the size-dependent RNA content of lipid nanoparticle-based RNA formulations, J Chromatogr, B: Anal Technol Biomed Life Sci, 1186, 10.1016/j.jchromb.2021.123015 · DOI
- Hedegaard, 2018, Fluorophore labeling of a cell-penetrating peptide significantly alters the mode and degree of biomembrane interaction, Sci Rep, 8, 6327, 10.1038/s41598-018-24154-z · doi:10.1038/s41598-018-24154-z
- Majzoub, 2015, Fluorescence microscopy colocalization of lipid-nucleic acid nanoparticles with wildtype and mutant Rab5-GFP: a platform for investigating early endosomal events, Biochim. Biophys. Acta, 1848, 1308, 10.1016/j.bbamem.2015.03.001 · DOI
- Munson, 2021, A high-throughput Galectin-9 imaging assay for quantifying nanoparticle uptake, endosomal escape and functional RNA delivery, Commun. Biol., 4, 211, 10.1038/s42003-021-01728-8 · DOI
- Sarode, 2022, Predictive high-throughput screening of PEGylated lipids in oligonucleotide-loaded lipid nanoparticles for neuronal gene silencing, Nanoscale Adv, 4, 2107, 10.1039/D1NA00712B · DOI
- Quagliarini, 2022, Mechanistic insights into the superior DNA delivery efficiency of multicomponent lipid nanoparticles: an in vitro and in vivo study, ACS Appl Mater Interfaces, 14, 56666, 10.1021/acsami.2c20019 · DOI
- Wilson, 2015, Real time measurement of PEG shedding from lipid nanoparticles in serum via NMR spectroscopy, Mol Pharm, 12, 386, 10.1021/mp500400k · DOI
- Paracini, 2023, Structural characterization of nanoparticle-supported lipid bilayer arrays by grazing incidence X-ray and neutron scattering, ACS Appl Mater Interfaces, 10.1021/acsami.2c18956 · doi:10.1021/acsami.2c18956
- Daniel, 2022, Quality by Design for enabling RNA platform production processes, Trends Biotechnol, 40, 1213, 10.1016/j.tibtech.2022.03.012 · DOI
- Clifton, 2020, Design and use of model membranes to study biomolecular interactions using complementary surface-sensitive techniques, Adv Colloid Interface Sci, 277, 10.1016/j.cis.2020.102118 · DOI
- Spadea, 2022, Nucleic acid-loaded lipid nanoparticle interactions with model endosomal membranes, ACS Appl Mater Interfaces, 14, 30371, 10.1021/acsami.2c06065 · DOI
- Aliakbarinodehi, 2022, Interaction kinetics of individual mRNA-containing lipid nanoparticles with an endosomal membrane mimic: dependence on pH, protein corona formation, and lipoprotein depletion, ACS Nano, 16, 20163, 10.1021/acsnano.2c04829 · DOI
- Sebastiani, 2021, Screening of the binding affinity of serum proteins to lipid nanoparticles in a cell free environment, J Colloid Interface Sci
- Kulkarni, 2019, On the role of helper lipids in lipid nanoparticle formulations of siRNA, Nanoscale, 11, 21733, 10.1039/C9NR09347H · DOI · Paper page
- Li, 2023, Acidification-induced structure evolution of lipid nanoparticles correlates with their in vitro gene transfections, ACS Nano
- Semple, 2005, Immunogenicity and rapid blood clearance of liposomes containing polyethylene glycol-lipid conjugates and nucleic Acid, J Pharmacol Exp Therapeut, 312, 1020, 10.1124/jpet.104.078113 · DOI · Paper page
- Chen, 2016, Measurement of pre-existing IgG and IgM antibodies against polyethylene glycol in healthy individuals, Anal Chem, 88, 10661, 10.1021/acs.analchem.6b03109 · DOI · Paper page
- Francia, 2020, The biomolecular corona of lipid nanoparticles for gene therapy, Bioconjugate Chem, 31, 2046, 10.1021/acs.bioconjchem.0c00366 · DOI · Paper page
- Parodi, 2015, Enabling cytoplasmic delivery and organelle targeting by surface modification of nanocarriers, Nanomedicine, 10, 1923, 10.2217/nnm.15.39 · DOI
- Anderluzzi, 2022, The role of nanoparticle format and route of administration on self-amplifying mRNA vaccine potency, J Contr Release, 342, 388, 10.1016/j.jconrel.2021.12.008 · DOI
- Trollmann, 2022, mRNA lipid nanoparticle phase transition, Biophys J, 121, 3927, 10.1016/j.bpj.2022.08.037 · DOI
- Davies, 2021, Functionalized lipid nanoparticles for subcutaneous administration of mRNA to achieve systemic exposures of a therapeutic protein, Mol Ther Nucleic Acids, 24, 369, 10.1016/j.omtn.2021.03.008 · DOI
- Oude Blenke, 2023, The storage and in-use stability of mRNA vaccines and therapeutics: not A cold case, J Pharmaceut Sci, 112, 386, 10.1016/j.xphs.2022.11.001 · DOI · Paper page
- Packer, 2021, A novel mechanism for the loss of mRNA activity in lipid nanoparticle delivery systems, Nat Commun, 12, 6777, 10.1038/s41467-021-26926-0 · DOI · Paper page
- Suzuki, 2022, Design and lyophilization of lipid nanoparticles for mRNA vaccine and its robust immune response in mice and nonhuman primates, Mol Ther Nucleic Acids, 30, 226, 10.1016/j.omtn.2022.09.017 · DOI
- Zhigaltsev, 2012, Bottom-up design and synthesis of limit size lipid nanoparticle systems with aqueous and triglyceride cores using millisecond microfluidic mixing, Langmuir, 28, 3633, 10.1021/la204833h · DOI · Paper page
- Johnson, 2003, Chemical processing and micromixing in confined impinging jets, AIChE J, 49, 2264, 10.1002/aic.690490905 · DOI · Paper page
- An, 2022, On the influence of nucleic acid backbone modifications on lipid nanoparticle morphology, Langmuir, 38, 14036, 10.1021/acs.langmuir.2c01492 · DOI
- Hassett, 2021, Impact of lipid nanoparticle size on mRNA vaccine immunogenicity, J Contr Release, 335, 237, 10.1016/j.jconrel.2021.05.021 · DOI · Paper page
Cited by
Strategies to reduce the risks of mRNA drug and vaccine toxicity
Bitounis, D., Jacquinet, E., Rogers, M. A., & Amiji, M. M. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00859-3 · Cited by 224
“These results raise questions about which other components of the LNP–mRNA complex or its biomolecular corona may stimulate membrane-associated TLRs, assuming the ionizable lipids are not abundantly displayed on the outermost layer of the particles 120,121 .”
Human T cell engineering via serial delivery of mRNA encapsulated within lipid nanoparticles
Ramamurthy, A., Scimonelli, G., Murphy, W. L., & Saha, K. (2026) · Molecular Therapy Nucleic Acids · doi:10.1016/j.omtn.2026.103081
Metadata
- Authors
- Cárdenas, M., Campbell, R. A., Yanez Arteta, M., Lawrence, M. J., & Sebastiani, F.
- Venue
- Current Opinion in Colloid & Interface Science
- Publisher
- Elsevier BV
- Published
- 2023-08
- Volume
- 66
- Pages
- 101705
- ISSN
- 1359-0294
- Cited by
- 103
- References
- 22
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 101 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.